Navigation Links
Open Source Clinical Trials Software Featured at the 46th DIA Annual Meeting
Date:6/13/2010

As open source becomes more prevalent in clinical research, key issues around open source technology are highlighted at leading industry events.

Washington, DC (PRWEB) June 11, 2010 -- Open source software will be a featured topic at this year’s annual meeting of the Drug Information Association (DIA). The DIA Annual Meeting is the premier event for professionals involved in the discovery, development, and life cycle management of pharmaceuticals, medical devices, and related products.

The largest provider of commercial open source clinical trials software, Akaza Research LLC, will be exhibiting and demonstrating the latest edition of their popular OpenClinica software at Booth #1944. OpenClinica is the world’s leading open source software for electronic data capture (EDC) and clinical data management. Cal Collins, the CEO of Akaza Research, will join other industry executives in panel discussion titled “Utilizing and Integrating Open Source Software in Clinical Research Environments.” Accompanying Mr. Collins will be Mark Paul, CEO of Statworks Inc., and Mark Adams, Project Manager of the NCI’s Cancer Biomedical Informatics Grid (caBIG) and Principal at Booz Allen Hamilton. The session will use real-world case studies to explore how open source software enhances flexibility, interoperability, and cost in clinical trials, and will take place on Thursday, June 17 at 8:30 in Room 152B.

About the Drug Information Association (DIA)

DIA is a neutral, global, professional, member-driven association of nearly 18,000 industry, academia, and regulatory professionals involved in the discovery and development of pharmaceuticals, medical devices, and related products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies, and services to improve health and well-being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China.

About OpenClinica®

OpenClinica is open source, web-based clinical trials software for electronic data capture (EDC) and clinical data management (CDM). OpenClinica facilitates study protocol configuration, data collection via electronic case report forms (eCRFs), and enables productive clinical trials management. OpenClinica supports 21 CFR Part 11, and other regulatory guidelines and is designed as a lightweight, standards-based, extensible, and modular platform. OpenClinica’s open source pricing model facilities a dramatically lower cost of use and ownership than proprietary, closed EDC and data management systems. All versions of OpenClinica are available for free download from http://www.openclinica.org.

About Akaza Research®

Akaza Research, the leading provider of open source clinical trial software, is headquartered in Waltham, Massachusetts. In collaboration with the 10,000 member OpenClinica open source community, Akaza has developed and commercialized OpenClinica under a professional open source model. Akaza brings Open Source Software (OSS) into the mainstream of the clinical research enterprise by making a robust, flexible, standards-based system accessible for all types of clinical research. Akaza Research provides OpenClinica Enterprise, a fully supported version of the OpenClinica platform with comprehensive support including installation, training, validation, upgrades, help desk support, customization, systems integration, and more. OpenClinica see www.akazaresearch.com.

###

Read the full story at http://www.prweb.com/releases/open-source/clinical-trials-software/prweb4115854.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related biology technology :

1. New Edition of Definitive Resource in Tissue Engineering Released Today
2. UniCare Unveils Community Resource Center in Topeka to Serve Medicaid Enrollees
3. Pharsight Achieves First License Sale for Public-Source Database
4. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
5. United BioSource Acquires Interest in Leading Adaptive Design Technology Service Provider
6. MichBio Issues 2007/8 Michigan Life Sciences Directory and Resources Guide
7. BioLife Solutions CryoStor(TM) Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New, Non-Embryonic Source of Stem Cells
8. United BioSource Acquires Caro Research, Leader in Simulation Modeling
9. Premier Research Appoints Global Head of Human Resources
10. RoundTable Healthcare Partners Closes Sale of MedAssist Holding, Inc. to Firstsource Solutions Limited
11. Halogen Software Wins Top Human Resource Product Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
(Date:6/23/2016)... ... 2016 , ... In a new case report published today in STEM CELLS ... developed lymphedema after being treated for breast cancer benefitted from an injection of stem ... with this debilitating, frequent side effect of cancer treatment. , Lymphedema refers ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):